Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
InVivo Therapeutics, a research and clinical-stage biomaterials and biotechnology company with a focus on the […]
CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Astellas and BMT CTN Announce Topline Results from Phase 3 MORPHO Trial of Gilteritinib
Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) today announced […]
Hikma Expands Impact in Canada with Launches of New Sterile Injectable Medicines
Hikma Pharmaceuticals, the multinational pharmaceutical company, announces the launch of four new sterile injectable medicines […]
Sian Eden & Olivia Houselander, Owen Mumford, on Medical Devices
In this video, Sian Eden and Olivia Houselander from Owen Mumford, a medical device company, […]
Alnylam Announces Appointment of Peter Kellogg to Board of Directors
Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to […]
Aldevron and Evanoa Sign Licensing Agreement
Evanoa Bioscience, a cell line developer for biologics manufacturing, together with Aldevron, a global leader […]
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
QIAGEN today announced it has entered into a strategic partnership with Servier, a global pharmaceutical […]
FDA Accepts Supplemental New Drug Application for Jardiance® for Children 10 years and Older with Type 2 Diabetes
The U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application (sNDA) for […]
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU
Telix Pharmaceuticals today announces presentations from the Company’s carbonic anhydrase IX (CAIX) targeting kidney and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more